Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Work In Process: 2023

Historic Work In Process for Zevra Therapeutics (ZVRA) over the last 1 years, with Dec 2023 value amounting to $1.9 million.

  • Zevra Therapeutics' Work In Process was N/A to $3.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $3.1 million, marking a year-over-year change of. This contributed to the annual value of $1.9 million for FY2023, which is N/A change from last year.
  • According to the latest figures from FY2023, Zevra Therapeutics' Work In Process is $1.9 million.
  • Over the past 5 years, Zevra Therapeutics' Work In Process peaked at $1.9 million during FY2023, and registered a low of $1.9 million during FY2023.
  • Moreover, its 1-year median value for Work In Process was $1.9 million (2023), whereas its average is $1.9 million.